Skip to content
Screener

Pre-Tax Income at other companies

CVS Health logo
CVS HealthCVS
$3.98B+141%
UnitedHealth Group logo
UnitedHealth GroupUNH
$6.97B+70.7%
TOI
TOITOI
-$2.49M+87.3%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$82.83M+823%
Elevance Health logo
Elevance HealthELV
$1.94B-15.5%
CareCloud, Inc. logo
CareCloud, Inc.CCLD
$1.22M-58.4%

Other financials

Income statement

See full
Revenue$652.5M+46.9%
Gross profit$80.8M-19.5%
Operating income-$9.6M-716%
Net income-$28.4M-42.6%
EPS (diluted)-$0.25+43.2%

Balance sheet

See full
Cash & equivalents$115.7M-23.4%
Total debt$970.4M+13.7%
Total equity$383.2M-57.2%
Total assets$2.0B-19.9%

Cash flow

See full
Operating cash flow-$9.3M+69.3%

Valuation

See full
Market cap$446.58M-58.2%
Enterprise value$1.3B-26.5%
P/S0.2×-0.3×

Profitability

See full
Gross margin17.2%+0.9pp
Operating margin-20.4%-22.4pp
Net margin-24.1%-35.8pp
FCF margin-9.7%

Returns & leverage

See full
Return on equity-79%-99.2pp
Debt / equity2.5×+1.6×
Current ratio1.2×+0.2×

Where this comes from

Reported directly by Evolent Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The source filing: Evolent Health, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:53 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628908-26-000086
Line itemFor the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
Loss on option exercise(196)(52,544)
Extinguishment of Series A Preferred Stock and other refinancing fees(9,000)(9,000)
Other income (expense), net109(35)851(83)
Loss before income taxes(25,649)(20,722)(51,371)(83,870)
Provision for (benefit from) income taxes2,715(825)3,625645
Loss before preferred dividends and accretion of Series A Preferred Stock(28,364)(19,897)(54,996)(84,515)
Dividends and accretion of Series A Preferred Stock(31,193)(38,825)
Net loss attributable to common shareholders of Evolent Health, Inc.$(28,364)$(51,090)$(54,996)$(123,340)

Item 1. Financial Statements

FAQ

What is Evolent Health, Inc.'s pre-tax income?
Evolent Health, Inc. (EVH) reported pre-tax income of -$25.65M in Q2 2026.
How has Evolent Health, Inc.'s pre-tax income changed year-over-year?
Evolent Health, Inc.'s pre-tax income decreased by 23.8% year-over-year, from -$20.72M to -$25.65M.
What is the long-term trend for Evolent Health, Inc.'s pre-tax income?
Over 4 years (2021 to 2025), Evolent Health, Inc.'s pre-tax income has grown at a 101.5% compound annual growth rate (CAGR), from -$32.4M to -$534.64M.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Ask your AI about Evolent Health, Inc.'s pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude